← 전체 보충제 목록

오메가3 (심장)

Omega-3 (Heart)

📑 PubMed 30편 ❤️ 심혈관

📚 관련 논문 (30편)

1.
Forensic Perspective of Unintentional Doping, Cardiovascular Health, and the Role of Nutrition in Competitive Sports.
Nutrients 2026 PMID:41829906

1. Nutrients. 2026 Feb 25;18(5):736. doi: 10.3390/nu18050736. Forensic Perspective of Unintentional Doping, Cardiovascular Health, and the Role of Nutrition in Competitive Sports. Šoša I(1). Author information: (1)Department of Anatomy, Faculty of Medicine, University of Rijeka, 51999 Rijeka, C

2.
Omega-3 fatty acids and cardiovascular risk-related metabolic markers in diverse populations: a meta-analysis of randomized trials.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2026 PMID:41494879

2. Nutr Metab Cardiovasc Dis. 2026 Apr;36(4):104488. doi: 10.1016/j.numecd.2025.104488. Epub 2025 Dec 3. Omega-3 fatty acids and cardiovascular risk-related metabolic markers in diverse populations: a meta-analysis of randomized trials. Chen C(1), Li X(2), Yan H(1), Liu J(1), Cao Y(3), Zhao H(1)

3.
The effectiveness of intervention with omega-3 fatty acids, eicosapentaenoic and docosahexenoic acid in peripheral arterial disease: a systematic review and meta-analysis.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2026 PMID:40940198

3. Nutr Metab Cardiovasc Dis. 2026 Jan;36(1):104286. doi: 10.1016/j.numecd.2025.104286. Epub 2025 Aug 30. The effectiveness of intervention with omega-3 fatty acids, eicosapentaenoic and docosahexenoic acid in peripheral arterial disease: a systematic review and meta-analysis. Dao TK(1), Nerlek

4.
Omega-3 fatty acid supplementation in solid organ transplant recipients: A systematic review and meta-analysis of randomized controlled trials.
Clinical nutrition ESPEN 2025 PMID:40912359

4. Clin Nutr ESPEN. 2025 Oct;69:809-820. doi: 10.1016/j.clnesp.2025.08.035. Epub 2025 Sep 3. Omega-3 fatty acid supplementation in solid organ transplant recipients: A systematic review and meta-analysis of randomized controlled trials. Samankan S(1), Gharekhani A(2), Khiali S(3), Rezagholizadeh

5.
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Advances in nutrition (Bethesda, Md.) 2025 PMID:40355028

5. Adv Nutr. 2025 Jun;16(6):100440. doi: 10.1016/j.advnut.2025.100440. Epub 2025 May 10. Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis. Amanat S(1), Dordevic AL(2), Brodtmann A(3), Cardoso BR(4). Author information: (1)Department of

6.
The Optimal Dosage and Duration of ω-3 PUFA Supplementation in Heart Failure Management: Evidence from a Network Meta-Analysis.
Advances in nutrition (Bethesda, Md.) 2025 PMID:39805484

6. Adv Nutr. 2025 Feb;16(2):100366. doi: 10.1016/j.advnut.2025.100366. Epub 2025 Jan 11. The Optimal Dosage and Duration of ω-3 PUFA Supplementation in Heart Failure Management: Evidence from a Network Meta-Analysis. Tseng PT(1), Zeng BY(2), Hsu CW(3), Liang CS(4), Stubbs B(5), Chen YW(6), Chen

7.
Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword.
Progress in cardiovascular diseases 2025 PMID:39617283

7. Prog Cardiovasc Dis. 2025 Jul-Aug;91:3-9. doi: 10.1016/j.pcad.2024.11.003. Epub 2024 Nov 30. Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword. O'Keefe EL(1), O'Keefe JH(2), Abuissa H(3), Metzinger M(1), Murray E(1), Franco G(1), Lavie CJ(4), Harris WS(5). Author i

8.
Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies.
Nutrients 2024 PMID:38892543

8. Nutrients. 2024 May 24;16(11):1610. doi: 10.3390/nu16111610. Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies. Xiao Y(1)(2)(3), Chen Y(2)(3), Pietzner A(2)(3), Elbelt U(2)(4), Fan Z(5), Weylandt KH(2)(3). Author inf

9.
Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
European journal of preventive cardiology 2024 PMID:38869144

9. Eur J Prev Cardiol. 2024 Nov 11;31(15):1863-1875. doi: 10.1093/eurjpc/zwae184. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis. Dinu M(1), Sofi F(1)(2), Lotti S(1), Colombini B(1), Mattioli AV(3), Catapano AL(4)(5), Casula M(4)(5), Barag

10.
Effect of omega-3 fatty acid supplementation on markers of inflammation and endothelial function in patients with chronic heart disease: A systematic review and meta-analysis.
Cellular and molecular biology (Noisy-le-Grand, France) 2024 PMID:38836663

10. Cell Mol Biol (Noisy-le-grand). 2024 Jun 5;70(6):171-177. doi: 10.14715/cmb/2024.70.6.26. Effect of omega-3 fatty acid supplementation on markers of inflammation and endothelial function in patients with chronic heart disease: A systematic review and meta-analysis. Ibrahim Mohialdeen Gubari

11.
Effect of compound fish oil capsules on microvascular function in hypertensive individuals: a triple-blind, randomized, placebo-controlled pilot trial.
Food & function 2026 PMID:41914515

11. Food Funct. 2026 Apr 27;17(8):3611-3624. doi: 10.1039/d5fo05343a. Effect of compound fish oil capsules on microvascular function in hypertensive individuals: a triple-blind, randomized, placebo-controlled pilot trial. Liu B(1)(2), Wang W(3), Teng A(4), Yu C(4), Liang Y(4), Liu A(4)(5), Wu X(2

12.
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetes.
Trials 2026 PMID:41749263

12. Trials. 2026 Feb 27;27(1):183. doi: 10.1186/s13063-026-09551-4. Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetes. Madurasinghe VW(1), Mafham M(2), Buck G(2)

13.
The effects of marine fatty acid omega-3 supplements on incident fractures and bone mineral density in generally healthy adults.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2026 PMID:41603552

13. J Bone Miner Res. 2026 Mar 2;41(3):242-250. doi: 10.1093/jbmr/zjaf172. The effects of marine fatty acid omega-3 supplements on incident fractures and bone mineral density in generally healthy adults. LeBoff MS(1)(2), Chou SH(1), Ratnarajah DM(1), Cook NR(2)(3)(4), Khurana B(2)(5), Kim E(3),

14.
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
The New England journal of medicine 2026 PMID:41201837

14. N Engl J Med. 2026 Jan 8;394(2):128-137. doi: 10.1056/NEJMoa2513032. Epub 2025 Nov 7. Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. Lok CE(1)(2)(3), Farkouh M(4)(5), Hemmelgarn BR(6), Moist LM(7), Polkinghorne KR(8), Tomlinson G(3), Tam P(9), Tonelli

15.
Effects of Prenatal DHA Dose on Infant Visual Attention.
Developmental psychobiology 2025 PMID:40791013

15. Dev Psychobiol. 2025 Sep;67(5):e70072. doi: 10.1002/dev.70072. Effects of Prenatal DHA Dose on Infant Visual Attention. Colombo J(1), Shaddy DJ(2), Mathis N(2), Christifano DN(2), Brown AR(3), Gajewski BJ(3), Carlson SE(2), Gustafson KM(4). Author information: (1)Department of Psychology and

16.
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial.
Circulation. Arrhythmia and electrophysiology 2025 PMID:40709466

26. Circ Arrhythm Electrophysiol. 2025 Aug;18(8):e013378. doi: 10.1161/CIRCEP.124.013378. Epub 2025 Jul 25. 2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial. Yoneda ZT(1), O'Neill M(2), Crawford DM(1), Ao M(3), Sun L(4), El-Harasis MA(1), Pitchfor

17.
Consuming grass finished lamb improves blood plasma ω-3 fatty acid response among healthy consumers.
European journal of nutrition 2025 PMID:40690019

27. Eur J Nutr. 2025 Jul 21;64(5):242. doi: 10.1007/s00394-025-03765-z. Consuming grass finished lamb improves blood plasma ω-3 fatty acid response among healthy consumers. Perkins LS(1), Nugent AP(1)(2), Woodside JV(1)(3), Cardwell CR(3), Scollan ND(4). Author information: (1)The Institute for

18.
An Adapted Cardioprotective Diet with or Without Phytosterol and/or Krill Oil Supplementation in Familial Hypercholesterolemia: Results of a Pilot Randomized Clinical Trial.
Nutrients 2025 PMID:40573119

14. Nutrients. 2025 Jun 15;17(12):2008. doi: 10.3390/nu17122008. An Adapted Cardioprotective Diet with or Without Phytosterol and/or Krill Oil Supplementation in Familial Hypercholesterolemia: Results of a Pilot Randomized Clinical Trial. de Abreu-Silva EO(1)(2), Machado RHV(1), Dos Santos BR(1)

19.
Identification of individuals who benefit from omega-3 fatty acid supplementation to prevent coronary heart disease: a machine-learning analysis of the VITAL.
European journal of epidemiology 2025 PMID:40569483

26. Eur J Epidemiol. 2025 Jul;40(7):803-813. doi: 10.1007/s10654-025-01259-0. Epub 2025 Jun 26. Identification of individuals who benefit from omega-3 fatty acid supplementation to prevent coronary heart disease: a machine-learning analysis of the VITAL. Hamaya R(1)(2), Cook NR(3)(4), Sesso HD(

20.
Differential cardiovascular impact of ω-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial.
Atherosclerosis 2025 PMID:40451708

47. Atherosclerosis. 2025 Sep;408:120228. doi: 10.1016/j.atherosclerosis.2025.120228. Epub 2025 May 28. Differential cardiovascular impact of ω-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial. Wang TKM(1),

21.
Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice.
The Journal of nutrition 2021 PMID:33851198

3. J Nutr. 2021 May 11;151(5):1175-1189. doi: 10.1093/jn/nxab002. Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice. Valle M(1)(2), Mitchell PL(1)(2), Pilon G(1)(2), St-Pierre P(1)(2), Vari

22.
Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 PMID:33113428

40. Biomed Pharmacother. 2020 Dec;132:110876. doi: 10.1016/j.biopha.2020.110876. Epub 2020 Oct 28. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity. Lages EB(1

23.
A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease.
The Journal of clinical psychiatry 2019 PMID:31163106

12. J Clin Psychiatry. 2019 Jun 4;80(4):19m12742. doi: 10.4088/JCP.19m12742. A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease. Carney RM(1)(2), Freedland KE(2), Rubin EH(2), Rich MW(3), Steinmeyer BC(2), Harris WS(4)

24.
Dietary modulators of statin efficacy in cardiovascular disease and cognition.
Molecular aspects of medicine 2014 PMID:24813475

28. Mol Aspects Med. 2014 Aug;38:1-53. doi: 10.1016/j.mam.2014.04.001. Epub 2014 May 9. Dietary modulators of statin efficacy in cardiovascular disease and cognition. Wang H(1), Blumberg JB(1), Chen CY(1), Choi SW(2), Corcoran MP(1), Harris SS(1), Jacques PF(1), Kristo AS(1), Lai CQ(1), Lamon-Fa

25.
Polyunsaturated omega-3 fatty acids improve responsiveness to clopidogrel after percutaneous coronary intervention in patients with cytochrome P450 2C19 loss-of-function polymorphism.
Kardiologia polska 2012 PMID:22623230

24. Kardiol Pol. 2012;70(5):439-45. Polyunsaturated omega-3 fatty acids improve responsiveness to clopidogrel after percutaneous coronary intervention in patients with cytochrome P450 2C19 loss-of-function polymorphism. Gajos G(1), Zalewski J, Nessler J, Zmudka K, Undas A, Piwowarska W. Author

26.
Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats.
Cancer chemotherapy and pharmacology 2012 PMID:22610354

11. Cancer Chemother Pharmacol. 2012 Jul;70(1):17-23. doi: 10.1007/s00280-012-1884-0. Epub 2012 May 18. Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats. Hajjaji N(1), Besson P, Bougnoux P. Author information: (1)Cancer Research Lab

27.
N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status.
European journal of clinical pharmacology 2012 PMID:22367427

33. Eur J Clin Pharmacol. 2012 Aug;68(8):1139-46. doi: 10.1007/s00228-012-1235-4. Epub 2012 Feb 25. N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status. Doenyas-Barak K(1), Berman S,

28.
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.
European heart journal 2012 PMID:22301766

32. Eur Heart J. 2012 Jul;33(13):1582-8. doi: 10.1093/eurheartj/ehr499. Epub 2012 Feb 1. Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eussen SR(1), Geleijnse JM, Giltay EJ, Rompelberg CJ, Klungel OH, Kromhout D.

29.
Supplementation of glutamine and omega-3 polyunsaturated fatty acids as a novel therapeutic intervention targeting metabolic dysfunction and exercise intolerance in patients with heart failure.
Current clinical pharmacology 2011 PMID:22082326

48. Curr Clin Pharmacol. 2011 Nov;6(4):288-94. doi: 10.2174/157488411798375958. Supplementation of glutamine and omega-3 polyunsaturated fatty acids as a novel therapeutic intervention targeting metabolic dysfunction and exercise intolerance in patients with heart failure. Shahzad K(1), Chokshi

30.
Fish oil: what is the role in cardiovascular health?
Journal of pharmacy practice 2012 PMID:21676848

18. J Pharm Pract. 2012 Feb;25(1):69-74. doi: 10.1177/0897190011406983. Fish oil: what is the role in cardiovascular health? Brinson BE(1), Miller S. Author information: (1)University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA. betsy.stainback@gmail.com Fish and fish oi

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.